← Leaderboards
Arthur Edward Frankel
Medical University Of South Carolina
$3,684,636
Attributed
$3,684,636
Total exposure
5
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $524.5K · FY2005–06$1M$750K$500K$250K$0
'05
'06
Funding mix
By agency
NIH$3,684,636 · 5
By mechanism
R01$2,951,195 · 2
R21$716,000 · 1
M01$17,441 · 2
Top collaborators
No co-investigators on record.
Most similar at Medical University Of South Carolina
Same institution · by research overlap
- Daohong Zhou$16,846,361
- Chiara Luberto$3,768,458
- Chung-Jen James Chou$1,864,135
- Harold D May$1,553,664
- Eleanor K Spicer$832,200
Others in their field
Top investigators on “Acute Myelogenous Leukemia”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$158,144,386
- Todd A Alonzo · University Of Colorado Denver/Hsc Denver$72,436,447
- Brad H. Pollock · University Of Florida$28,646,726
- Gregory H Reaman · National Childhood Cancer Foundation$17,689,961
- Richard Aplenc · University Of Pennsylvania$16,894,374
- Daniel G Tenen · Beth Israel Deaconess Medical Center$16,073,131
Research focus
Acute Myelogenous LeukemiaHuman SubjectClinical Trial Phase IChimeric ProteinsAntineoplasticsDrug Screening /EvaluationColony Stimulating FactorHuman Therapy EvaluationPatient Oriented ResearchDiphtheria ToxinPharmacokineticsScid MouseToxin MetabolismNeoplasm /Cancer ImmunotherapyCytotoxicityImmunologic Assay /TestInterleukin 3Neoplasm /Cancer Relapse /RecurrenceNeoplasm /Cancer ChemotherapyCytokineLaboratory RatLiverAdult Human (21+)Combination Cancer Therapy
Grant awards (18)
Diphtheria fusion protein therapy of AML$277,672
R01 · FY2006 · CA · contact PI
Targeting protein synthesis in AML$246,820
R01 · FY2006 · CA · contact PI
Targeting protein synthesis in AML$251,171
R01 · FY2005 · CA
Diphtheria fusion protein therapy of AML$165,844
R01 · FY2005 · CA
Diphtheria fusion protein therapy of AML$104,903
R01 · FY2005 · CA
Diphtheria fusion protein therapy of AML$270,747
R01 · FY2004 · CA
Targeting protein synthesis in AML$257,617
R01 · FY2004 · CA
Diphtheria fusion protein therapy of AML$294,707
R01 · FY2003 · CA
Targeting protein synthesis in AML$256,320
R01 · FY2003 · CA
Combination fusion toxin and cytarabine therapy of AML$353,500
R21 · FY2002 · CA
Diphtheria fusion protein therapy of AML$276,688
R01 · FY2002 · CA
Targeting protein synthesis in AML$256,320
R01 · FY2002 · CA
DTGM FUSION PROTEIN IND8153 IN ACUTE MYELOID LEUKEMIA$0
M01 · FY2002 · RR
Combination fusion toxin and cytarabine therapy of AML$362,500
R21 · FY2001 · CA
RICIN FUSION TOXIN THERAPY OF RESISTANT LEUKEMIAS$97,462
R01 · FY2001 · CA
RICIN FUSION TOXIN THERAPY OF RESISTANT LEUKEMIAS$194,924
R01 · FY2000 · CA
ANTI CD7 IMMUNOTOXIN$17,441
M01 · FY2000 · RR
DTGM FUSION PROTEIN IND8153 IN ACUTE MYELOID LEUKEMIA$0
M01 · FY2000 · RR